https://www.selleckchem.com/pr....oducts/envonalkib.ht
Conclusions We found that glycaemic control was too tight in at least 36.5% of the total population and that 40% of patients with HbA1C less then 7% were potentially overtreated. The use of dipeptidyl peptidase 4 (DPP-4) inhibitors was still insufficient, as was CBGM. Avoiding hypoglycaemia is one of the priorities in the management of older patients with diabetes. Therefore, NHs should focus on improving the use of glycaemic targets and antidiabetic drugs that do not induce hypoglycaemia, as well as better monitoring of capillary bl
Like
Comment
Share
